Sponsors

Early diagnosis of RA

  •  

The Binding SiteÆs new, highly specific and sensitive secondgeneration anti-CCP2 enzyme-linked immunosorbent assay (ELISA) kit is the latest addition to the companyÆs comprehensive range of autoimmune BINDAZYME assays.

The kit is intended as an aid in the early diagnosis of rheumatoid arthritis, measuring specific IgG autoantibodies against secondgeneration cyclic citrullinated peptides (CCP2) in human serum.

In common with all BINDAZYME assays, the new anti-CCP2 kit is automation friendly and easy to use. Its single-well ‘break apart’ format makes it cost effective and suitable for various levels of workload.

www.bindingsite.co.uk

Other News

Immune 'hijacking' predicts cancer evolution

News

Feb 06, 2026
Newcastle Lynch syndrome test is rolled out across the UK for patients

News

Feb 05, 2026
RSV vaccination programme extended

News

Feb 03, 2026
Improving safety, transparency and confidence in AI healthcare tools

News

Feb 03, 2026
Data science educational for laboratory medicine professionals

News

Feb 03, 2026
A closed-loop recycling solution for laboratory plastics

News

Feb 03, 2026
Register now for the BSMT Annual Microbiology Conference

News

Feb 02, 2026
Partnership supporting improved UTI diagnosis

News

Feb 02, 2026
A rapid sterility test designed for super-fast results

News

Feb 02, 2026

Latest Issues

UK NEQAS


UK NEQAS IMPROVES PATIENT CARE
We aim to improve patient care through monitoring the quality of tests and their reporting, in an independent manner and on a not-for-profit basis.
We are here to help ensure optimal quality in testing for the benefit of patients.
We believe that the result of tests should be:

Learn more »

BIVDA Regulatory Affairs Seminar

Grand Hotel, Birmingham
10 - 11 February, 2026

BDIAP Molecular Pathology Study Day

10 Union Street, London, SE1 1SZ
2 March, 2026

Cell & Gene Therapy 2026

Hinxton Hall Conference Centre, Wellcome Genome Campus, Hinxton, CB10 1RQ
9-10 March, 2026